Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia. (Q38423854)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 September 2014

Language	Label	Description	Also known as
English	Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia.	scientific article published on 12 September 2014

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Raffaella Origa

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Maria Domenica Cappellini

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1

object named as

Ali T Taher

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Vip Viprakasit

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Antonis Kattamis

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Suporn Chuncharunee

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Pranee Sutcharitchan

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Noppadol Siritanaratkul

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Zeynep Karakas

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Dany Habr

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Zewen Zhu

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

0 references

publication date

12 September 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

British Journal of Haematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

168

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

284-290

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13119

21 January 2018

Heterogeneity of hemoglobin H disease in childhood

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13119

21 January 2018

Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13119

21 January 2018

Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with β-thalassemia intermedia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13119

21 January 2018

Non-transfusion-dependent thalassemias

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13119

21 January 2018

Liver iron concentrations and urinary hepcidin in beta-thalassemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13119

21 January 2018

The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13119

21 January 2018

Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13119

21 January 2018

Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13119

21 January 2018

Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13119

21 January 2018

Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: the safety profile of deferasirox

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13119

21 January 2018

Hemoglobin e syndromes

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13119

21 January 2018

The definition and epidemiology of non-transfusion-dependent thalassemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13119

21 January 2018

Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13119

21 January 2018

Identifiers

10.1111/BJH.13119

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212456%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38423854&oldid=1509032115"